קונבריזה

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

BAZEDOXIFENE AS ACETATE 20 MG

Mevcut itibaren:

NEOPHARM LTD

ATC kodu:

G03XC02

Farmasötik formu:

COATED TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

PFIZER IRELAND PHARMACEUTICALS

Terapötik grubu:

BAZEDOXIFENE

Terapötik endikasyonlar:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

Yetkilendirme tarihi:

2013-04-01